Home › Pulmonary Hypertension › NCT03269630
New Orleans Pulmonary Hypertension Biobank
Who can join
Ages 18 and older · All sexes · Healthy volunteers welcome
Full eligibility criteria
Inclusion Criteria: * Diagnosis of pulmonary hypertension and followed at the Comprehensive Pulmonary Hypertension Center OR * Diagnosis of systemic sclerosis and followed at the Comprehensive Pulmonary Hypertension Center OR * Diagnosis of mixed connective tissue disease and followed at the Comprehensive Pulmonary Hypertension Center OR * Undergoing outpatient right heart catheterization Exclusion Criteria: * Age\<18 * Pregnant * Unable to understand English * Currently incarcerated * Unwilling or unable to sign informed consent
About the study
Pulmonary hypertension (PH) is a serious condition characterized by a mean pulmonary artery pressure \>=25mmHg on right heart catheterization (RHC). Despite advances in PH care, outcomes are still sub-optimal and further research is required into the pathobiology of the disease and development of biomarkers that can guide clinical care. The investigators are establishing a biobank to collect samples (blood, urine, stool) from patients with pulmonary hypertension, patients at high risk for pulmonary hypertension, healthy controls, and patients undergoing right heart catheterization. Specimens will be stored for future investigations.
What is being tested
- No intervention. Biospecimen collection only (other)
Sponsor: Louisiana State University Health Sciences Center in New Orleans · Participants: 450 · Started: Dec 29, 2017
Contact the study team
- Matthew R Lammi, MD, MSCR · Phone: 5045684634
Official record on ClinicalTrials.gov — NCT03269630
Locations in the U.S.
| Louisiana | University Medical Center-New Orleans, New Orleans |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.